Merck, BMS Target Cipla USA Over Generic HIV Drug Sustiva
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. brought patent infringement allegations in New Jersey federal court Thursday against Indian generics maker Cipla USA Inc. over the company's plans to...To view the full article, register now.
Already a subscriber? Click here to view full article